Stock Events

Roche 

CHF274.2
1302
-CHF2.3-0.83% Friday 15:30

Statistics

Day High
278.3
Day Low
273.5
52W High
288.2
52W Low
212.9
Volume
1,142,423
Avg. Volume
1,204,378
Mkt Cap
231.1B
P/E Ratio
21.69
Dividend Yield
3.34%
Dividend
9.15

Upcoming

30
JAN 25
Earnings
 
14
MAR 25
Dividend Ex
Estimated
 
18
MAR 25
Dividend Payment
Estimated
 
14
MAR 26
Dividend Ex
Estimated
 
18
MAR 26
Dividend Payment
Estimated
 

Dividends

3.34%Dividend Yield
Mar 24
CHF9.6
Mar 23
CHF9.5
Mar 22
CHF9.3
Mar 21
CHF9.1
Mar 20
CHF9
10Y Growth
2.01%
5Y Growth
4.75%
3Y Growth
3.42%
1Y Growth
6.18%

Earnings

23JulExpected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
3.44
6.87
10.31
Expected EPS
9.2833536824
Actual EPS
10.1408124048

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ROG.SW. It's not an investment recommendation.
Alphabet
72554
GOOGL
Apple
63389
AAPL
Microsoft
59081
MSFT
Amazon
54705
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap244.75B
Novartis competes directly with Roche in multiple areas including oncology, neuroscience, and immunology, making it a primary competitor.
Pfizer
PFE
Mkt Cap164.39B
Pfizer competes with Roche in the pharmaceutical sector, particularly in the development of cancer and immunology drugs.
Merck
MRK
Mkt Cap300.25B
Merck is a key competitor in the oncology space, directly competing with Roche's cancer drug portfolio.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals that overlap with Roche's offerings.
Abbvie
ABBV
Mkt Cap346.75B
AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Roche's interests.
AMGEN
AMGN
Mkt Cap179.38B
Amgen competes with Roche in the biotech sector, especially in cancer and hematology.
Bristol-Myers Squibb
BMY
Mkt Cap101.27B
Bristol Myers Squibb competes in the pharmaceutical and biopharmaceutical sectors, particularly in cancer, which is a key area for Roche.
GSK
GSK
Mkt Cap89.55B
GlaxoSmithKline competes with Roche in several areas including pharmaceuticals and vaccines.
Sanofi
SNY
Mkt Cap141.43B
Sanofi competes with Roche in the pharmaceutical sector, including treatments for rare diseases, which Roche also focuses on.
Astrazeneca
AZN
Mkt Cap271.67B
AstraZeneca competes with Roche in the development of drugs for various diseases, including cancer, respiratory, and cardiovascular diseases.

About

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Show more...
CEO
Dr. Severin Schwan Ph.D.
Employees
103605
Country
CH
ISIN
CH0012032048

Listings

US
RHHBF
US
RHHVF
SW
CH
RO.SW
LSE
GB
0QQ6.LSE